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Purpose: Under the South Korea’s unique health insurance structure, any new surgical technology must be evaluated first 
by the government in order to consider whether that particular technology can be applied to patients for further clinical 
trials as categorized as ‘New Health Technology,’ then potentially covered by the insurance sometime later. The aim of 
this meta-analysis was to assess the safety and efficacy of transanal total mesorectal excision (TaTME) for rectal cancer, 
activated by the National Evidence-based Healthcare Collaborating Agency (NECA) TaTME committee.
Methods: We systematically searched Ovid-MEDLINE, Ovid-Embase, Cochrane, and Korean databases (from their 
inception until August 31, 2019) for studies published that compare TaTME with laparoscopic total mesorectal excision 
(LaTME). End-points included perioperative and pathological outcomes.
Results: Sixteen cohort studies (7 for case-matched studies) were identified, comprising 1,923 patients (938 TaTMEs and 
985 LaTMEs). Regarding perioperative outcomes, the conversion rate was significantly lower in TaTME (risk ratio, 0.19; 
95% confidence interval, 0.11–0.34; P < 0.001); whereas other perioperative outcomes were similar to LaTME. There were 
no statistically significant differences in pathological results between the 2 procedures.
Conclusion: Our meta-analysis showed comparable results in preoperative and pathologic outcomes between TaTME 
and LaTME, and indicated the benefit of TaTME with low conversion. Extensive evaluations of well-designed, multicenter 
randomized controlled trials are required to come to unequivocal conclusions, but the results showed that TaTME is a 
potentially beneficial technique in some specific cases. This meta-analysis suggests that TaTME can be performed for 
rectal cancer patients as a ‘New Health Technology’ endorsed by NECA in South Korea.
[Ann Surg Treat Res 2021;101(3):167-180]
Key Words: Colorectal neoplasms, Laparoscopic total mesorectal excision, Meta-analysis, Systematic review, Transanal 
total mesorectal excision  
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INTRODUCTION
Colorectal cancer is the third most common diagnosis and 
the third-leading cause of death worldwide [1]. Total mesorectal 
excision (TME) was first described by Heald and Ryall in 
1982 [2], and it has become the standard treatment for rectal 
cancer by effectively reducing recurrence, improving quality 
of life, and prolonging survival [3]. Laparoscopic surgery has 
replaced open surgery, allowing favorable short-term outcomes, 
particularly for pain reduction, reduced blood loss, and rapid 
recovery [4]. Laparoscopic surgery has been widely accepted 
and used for minimally invasive surgical procedures; however, 
conversions from laparoscopic TME (LaTME) to open procedure 
have been common in patients with rectal cancer [5]. The main 
reasons for the unsatisfactory conversion rate were the patient 
characteristics of male sex (because of the narrow pelvis) 
and the high body mass index (BMI) [6,7]. Additionally, high 
incidence of positive resection margin and poor quality of TME 
specimen, which are factors known as poor oncologic outcomes 
in deep narrow pelvis, exist [8].
To address the aforementioned limitations, transanal TME 
(TaTME) was first described by Sylla et al. [9]. In several studies, 
this “bottom-up” approach for mid-low rectal cancer has been 
proposed as a safe and effective technique for patients by 
demonstrating the benefits of more precise excision under 
appropriate visualization and potentially improving specimen 
quality and resection margins [10-12]. However, it still remains 
controversial because its oncological feasibility and safety 
have not yet been validated by large randomized controlled 
trials (RCTs). Recent studies reported that the TaTME approach 
showed unfavorable local recurrence rates and a higher risk of 
anastomotic leak than a nontransanal approach [13,14]. TaTME 
also seems to be associated with substantial morbidities such 
as urethral and other urologic injuries [15]. It is suggested that 
these complications are related to the surgeon’s lack of surgical 
training or learning curves [16,17].
The national health insurance system of South Korea is 
unique public health insurance where all citizens are forced to 
sign in, and all insurance policyholders are burdened with the 
duty to pay for the insurance. By the unique structure of South 
Korea’s health insurance system, if a new medical procedure 
doesn’t pass the New Health Technology Assessment (nHTA), 
it cannot be covered by the health insurance, thus not being 
available to policyholders even as an uncovered procedure. 
Therefore, nHTA is an essential step undertaken to evaluate 
whether a procedure’s clinical safety/efficacy is appropriate 
to be used on insurance policyholders through a systematic 
review.
TaTME is a new surgical technique in which the technical 
method of conventional LaTME has been changed and is 
subject to nHTA. Thus, a systematic review and meta-analysis 
of the current data from the latest and most convincing studies 
was conducted, comparing the safety and efficacy between 
TaTME and LaTME for nHTA by the National Evidence-based 
Healthcare Collaborating Agency (NECA) committee.
METHODS
Registration and search strategy
This study was conducted in accordance with the PRISMA 
(preferred reporting items for systematic reviews and meta-
analyses) guidelines [18]. The protocol was registered 
in PROSPERO under the number CRD42021230076. 
Comprehensive searches were performed through the 
databases of MEDLINE, Embase, Cochrane Library, and Korean 
databases (KoreaMed, KMbase, KISTI, KISS, and RISS) from 
their inception until August 31, 2019. The MEDLINE and 
Embase databases were searched using the following terms 
with Boolean operators: (rectal neoplasms OR rectal tumor OR 
rectal cancer OR colorectal neoplasms OR colorectal tumor OR 
colorectal cancer) AND (transanal total mesorectal excision OR 
TaTME OR Ta-TME OR transanal minimally invasive surgery 
OR TAMIS OR transanal endoscopic surgery OR transanal rectal 
resection). The Cochrane database was searched using the 
following keyword: transanal total mesorectal excision. The 
Korean database was searched using the following terms with 
Boolean operators: neoplasms AND transanal total mesorectal 
excision.
Inclusion and exclusion criteria
In accordance with PICOS (patient, intervention, comparator, 
outcome, and study design) criteria, studies were included if 
they met the following inclusion criteria: (1) patients diagnosed 
with rectal cancer; (2) patients underwent either TaTME or 
LaTME; (3) at least 1 of the following perioperative outcomes 
or pathological data were available; and (4) studies were cohort 
studies. The exclusion criteria were as follows: (1) reviews, 
letters, editorials, commentaries, conference abstract, and 
clinical reports; (2) studies with sample size below 20 in each 
group; (3) languages other than English; (4) inappropriate 
data; (5) duplicate patient series; (6) inadequate technique for 
intervention or comparator; and (7) nonhuman researches.
Data extraction and quality assessment
The following data were extracted by the 2 reviewers 
(SHK and YIJ). (1) Demographic data: study design, sex, BMI, 
age, American Society of Anesthesiologists physical status 
classification, tumor location, and neoadjuvant treatment; 
(2) Perioperative outcomes: operation time, intraoperative 
blood loss, conversion rate, hospital stay, readmission, 
reoperation, diverting ileostomy, major complication (Clavien-
Dindo classification III−V), anastomotic leakage, intestinal 
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obstruction, ureter or urethral injury, urinary retention, urinary 
tract infection, and mortality; (3) Pathological outcomes: 
circumferential resection margin (CRM) and distal resection 
margin (DRM) involvement, length of CRM and DRM, 
incompleteness of mesorectum, and harvested lymph nodes. 
The methodological quality and risk of bias of the included 
studies were assessed using the Newcastle−Ottawa quality 
assessment scale [19]. Any disagreements were settled by 
consensus-based discussion between the 2 reviewers (SHK and 
YIJ).
Definitions
Inappropriate techniques described in the exclusion criteria 
are defined as all procedures except interventional (TaTME) or 
comparative procedures (LaTME). The location of the tumor is 
categorized as low (0–5 cm from the anal verge), middle (5.1–10 
cm from the anal verge), and high (10.1–15 cm from the anal 
verge). Conversion in LaTME was defined when the procedure 
was completed with open surgery. Conversion in TaTME was 
defined as a case in which the procedure was completed by 
open surgery, or the TME was performed by the transanal 
approach but the conversion occurred at the transabdominal 
phase. Mesorectal resection quality was scored using 3 grades—
complete, nearly complete, or incomplete, as defined by Quirke 
et al. [20]. 
Statistical analysis
Meta-analyses were performed with Review Manager 5.3 
software (Cochrane Collaboration, Oxford, UK). Dichotomous 
data were pooled as risk ratios (RRs) with 95% confidence 
intervals (CIs) using the Mantel-Haenszel method, which 
can avoid biased estimates by incorporating evidence from 
single zero studies without requiring the standard continuity 
correction [21]. Mean differences (MDs) and 95% CI were pooled 
for continuous variables using the inverse variance method. 
If the median and range were reported instead of the mean 
and standard deviation, these values were estimated using the 
method devised by Hozo et al. [22]. The Q test and I2 statistic 
were used to evaluate heterogeneity among studies. The 
Cochrane Handbook for Systematic Reviews of Interventions 
provides a rule of thumb for interpreting the I2 statistic; that is 
I2 ≤ 40% may indicate unimportant heterogeneity, 30% ≤ I2 ≤ 
60% may represent moderate heterogeneity, 50% ≤ I2 ≤ 90% 
may represent substantial heterogeneity, and 70% ≤ I2 ≤ 100% 
implies that heterogeneity may be considerable. A Cochrane 
Q statistical P < 0.100 and/or I2 > 50% was taken to indicate 
significant heterogeneity, in which case a random-effects 
model was applied [23]. Otherwise, a fixed-effects model was 
employed. Funnel plots were used in meta-analysis to visually 
detect the presence of publication bias.
RESULTS
Study characteristics
As a result of the literature search, 1,940 studies were 
identified. Among the search results obtained through the 
online databases in the first screening, 534 duplicate articles 
were removed. After that, through the review of the abstracts, 
857 articles that did not fit the language and article type were 
excluded. The remaining articles were fully checked to ensure 
they met the inclusion criteria, and 533 additional articles were 
excluded. Finally, 16 cohort studies met all the inclusion criteria 
and none of the exclusion criteria (Fig. 1) [24-39]. Seven of the 
cohort studies were case-matched studies comparing TaTME 
with LaTME for rectal cancer [25,28-31,36,38]. The patient 
demographics, clinical characteristics, and quality assessment 
scores are shown in Table 1 and Supplementary Table 1.
Perioperative outcomes
A total of 12 studies [24-28,30-32,34-36,38] reported operation 
time in 946 patients, and we found no statistically significant 
difference between TaTME and LaTME groups (MD, 7.52; 95% 
CI, –10.03−25.07; P = 0.400) (Fig. 2A). Perdawood et al. [35] 
and Fernández-Hevia et al. [24] reported a 2-team approach as 
standard; Alamili et al. [32], Chen et al. [34], Roodbeen et al. [36], 
Sparreboom et al. [38], Chang and Kiu [28], and Mege et al. [30] 
used a 1-team approach. Persiani et al. [31], Lelong et al. [37], 
Chen et al. [25], and Rasulov et al. [26] used both a 1- and 2-team 
approach. There was a notable heterogeneity between included 
studies (I2 = 88%, P < 0.001). 
Int raoperat ive blood loss  repor ted in 6  studies 
[25,26,28,32,34,35] that investigated 462 patients (Fig. 2B). There 
was no statistically significant difference between groups 
(MD, –8.37; 95% CI, –27.82−11.08; P = 0.410), and moderate 
heterogeneity was existed (I2 = 48%, P = 0.090). 
Data on conversion rate were extracted from 13 studies [24-
32,34-36,38] assessing 1,738 patients (Fig. 2C). Upon analysis, 
the TaTME group displayed significant lower conversion rate 
compared to the LaTME group (RR, 0.19; 95% CI, 0.11−0.34; P < 
0.001). There was no heterogeneity between included studies (I2 
= 0%, P = 0.460).
Twelve studies [24-32,34,36,38] assessed hospital stay in 
1,680 patients (Fig. 3A). Pooled analysis indicated that the result 
was not statistically significant between the 2 groups (MD, 
–0.51; 95% CI, –1.43−0.41; P = 0.280). Substantial heterogeneity 
existed in hospital stay (I2 = 88%, P < 0.001). 
A total of 7 studies [24,25,27,29,32,36,38] reported data on 
readmission in 1,326 patients (Fig. 3B). There was no statistically 
significant difference between the 2 groups (RR, 0.90; 95% CI, 
0.70−1.15; P = 0.400), and moderate heterogeneity existed (I2 = 
49%, P = 0.070).
Five studies [24,25,27,32,38] that evaluated 452 patients were 
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pooled for analysis of reoperation (Fig. 3C). The difference was 
not statistically significant between the 2 groups (RR, 0.86; 95% 
CI, 0.45−1.61; P = 0.630). There was no heterogeneity between 
included studies (I2 = 0%, P = 0.470). 
Analysis of the major complication (Clavien-Dindo 
classification III−V) was performed based on 9 studies 
[24,26,27,30,31,36-39] evaluating 629 patients (Fig. 4A). There 
was no statistically detected difference between the groups (RR, 
0.75; 95% CI, 0.50−1.13; P = 0.170). Heterogeneity in this regard 
was not significant (I2 = 0%, P = 0.640).
Data on anastomotic leakage were available in 9 studies 
[24,28-32,34,36,38], which assessed 1,196 patients (Fig. 4B). 
We found that there was no statistically significant difference 
between the 2 groups (RR, 1.32; 95% CI, 0.96−1.82; P = 0.090), 
with no heterogeneity (I2 = 26%, P = 0.210).
Intestinal obstruction was investigated in 8 studies 
[24,25,28,30-32,34,38], and remained unchanged between the 2 
groups (RR, 1.01; 95% CI, 0.59−1.72; P = 0.970) (Fig. 4C). There 
was no heterogeneity between included studies (I2 = 0%, P = 
0.940).
Moreover, the occurrence of other complications such as 
diverting ileostomy (RR, 1.20; 95% CI, 0.87−1.65; P = 0.270; I2 
= 85%), mortality within 30 days (RR, 0.40; 95% CI, 0.06−2.73; 
P = 0.350; I2 = 0%), ureter or urethral injury (RR, 0.83; 95% CI, 
0.10−6.63; P = 0.860; I2 = 0%), urinary retention (RR, 1.23; 95% 
CI, 0.04−38.46; P = 0.910; I2 = 74%), and urinary tract infection 
(RR, 1.08; 95% CI, 0.29−4.11; P = 0.910; I2 = 0%) were similar 
between the 2 groups (Supplementary Fig. 1, 2).
Pathological outcomes
Fifteen studies [24-31,33-39] that assessed 1,863 patients 
reported on CRM involvement (Fig. 5A). The results showed 
that CRM involvement was similar between the 2 groups (RR, 
0.73; 95% CI, 0.48−1.10; P = 0.130), and no heterogeneity was 
detected between included studies (I2 = 0%; P = 0.750).
The length of CRM was reported in 4 studies [24,32,35,36] that 
investigated 274 patients (Fig. 5B). The comparison between 
the 2 groups resulted in a difference that was not statistically 
significant (MD, 1.64; 95% CI, –1.32−4.60; P = 0.280), but there 
was a notable heterogeneity (I2 = 97%; P < 0.001).
Seven studies [26,27,30,35-38] assessed 467 patients and 
reported on DRM involvement (Fig. 5C). DRM involvement is 
not significantly different between the 2 groups (RR, 0.60; 95% 
CI, 0.32−1.15; P = 0.120), with no significant between-study 
heterogeneity (I2 = 0%, P = 0.880).
A total of 9 studies [24,25,28,30-32,34-36] reported length 
of DRM in 733 patients (Fig. 5D), which was not significantly 
different between the 2 groups (MD, 1.88; 95% CI, –2.96−6.73; 
P = 0.450). Statistical heterogeneity among the studies was high 
(I2 = 87%, P < 0.001).
Eleven studies [24,26,27,30-33,35-37,39] assessed 736 patients 
and provided data on incompleteness of mesorectum (Fig. 5E). 
Pooled analysis showed that the incompleteness of mesorectum 
was equivalent between the 2 groups (RR, 1.00; 95% CI, 





























Full-text articles excluded (n = 533)
Case series (n = 16)
Case reports (n = 47)
Sample size below 20 in each group (n = 15)
Unavailable/incomplete data (n = 32)
Duplicated data (n = 4)
Inadequate technique for TaTME (n = 415)
Inadequate technique for LaTME (n = 4)












Abstract excluded (n = 857)
Languages other than English (n = 118)
Review articles (n = 154)
Letters, expert opinions, commentaries,
other themes (n = 585)
Duplicates removed
(n = 534)
Fig. 1. PRISMA diagram of the 
search strategy. TaTME, transanal 
total mesorectal excision; LaTME, 
laparoscopic total mesorectal 
excision. 
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Heterogeneity: Tau = 753.83; Chi = 90.17, df = 11 (P < 0.001); I = 88%
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Heterogeneity: Chi = 9.67, df = 5 (P = 0.09); I = 48%
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Heterogeneity: Chi = 9.76, df = 10 (P = 0.46); I = 0%




























































M H, fixed, 95% CI
Favours TaTME Favours LaTME
Risk ratio


































Fig. 2. Forest plots of risk ratios and mean differences of perioperative outcomes. (A) Operative time, (B) intraoperative blood 
loss and, (C) conversion rate. A random-effect model was used for meta-analysis of operative time. Fixed-effects models were 
used for meta-analysis of intraoperative blood loss and conversion rate. Mean differences and risk ratios are shown with 95% 
confidence intervals (CIs). TaTME, transanal total mesorectal excision; LaTME, laparoscopic total mesorectal excision; SD, 
standard deviation; IV, inverse variance; df, degree of freedom.
 Annals of Surgical Treatment and Research 173
0.70−1.45; P = 0.980). There was no heterogeneity between 
included studies (I2 = 10%, P = 0.350).
Among the 9 studies [25-28,30,32,34-36] that evaluated 684 
patients, the difference in harvested lymph nodes was not 
statistically significant (MD, 0.44; 95% CI, –0.89−1.78; P = 0.520) 
(Fig. 5F). No significant heterogeneity existed between included 















Heterogeneity: Tau = 1.85; Chi = 90.68, df = 11 (P < 0.001); I = 88%
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Heterogeneity: Chi = 11.77, df = 6 (P = 0.07); I = 49%






































M H, fixed, 95% CI
Favours TaTME Favours LaTME
Risk ratio




























Heterogeneity: Chi = 3.57, df = 4 (P = 0.47); I = 0%






























M H, fixed, 95% CI
Favours TaTME Favours LaTME
Risk ratio



















Fig. 3. Forest plots of risk ratios and mean differences of perioperative outcomes. (A) Hospital stay, (B) readmission, and (C) 
reoperation. A random-effect model was used for meta-analysis of hospital stay. Fixed-effects models were used for meta-
analysis of readmission and reoperation. Mean differences and risk ratios are shown with 95% confidence intervals (CIs). 
TaTME, transanal total mesorectal excision; LaTME, laparoscopic total mesorectal excision; SD, standard deviation; IV, inverse 
variance; df, degree of freedom.
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Heterogeneity: Chi = 6.09, df = 8 (P = 0.64); I = 0%














































M H, fixed, 95% CI
Favours TaTME Favours LaTME
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Heterogeneity: Chi = 10.86, df = 8 (P = 0.21); I = 26%














































M H, fixed, 95% CI
Favours TaTME Favours LaTME
Risk ratio



































Heterogeneity: Chi = 2.35, df = 7 (P = 0.94); I = 0%










































M H, fixed, 95% CI
Favours TaTME Favours LaTME
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Fig. 4. Forest plots of risk ratios of perioperative outcomes. (A) Major complications (Clavien-Dindo classification III−V), (B) 
anastomotic leakage, and (C) intestinal obstruction. Fixed-effects models were used for meta-analysis. Risk ratios are shown 
with 95% confidence intervals (CIs). TaTME, transanal total mesorectal excision; LaTME, laparoscopic total mesorectal 
excision; df, degree of freedom.
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Heterogeneity: Chi = 7.62, df = 11 (P = 0.75); I = 0%



































































M H, fixed, 95% CI
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Heterogeneity: Tau = 7.61; Chi = 86.86, df = 3 (P < 0.001); I = 97%
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Heterogeneity: Chi = 2.40, df = 6 (P = 0.88); I = 0%






































M H, fixed, 95% CI
Favours TaTME Favours LaTME
Risk ratio






















Fig. 5. Forest plots of risk ratios and mean differences of pathological outcomes. (A) Circumferential resection margin 
involvement, (B) length of circumferential resection margin, (C) distal resection margin involvement, (D) length of distal 
resection margin, (E) incompleteness of mesorectum, and (F) harvested lymph nodes. Random-effects models were used for 
meta-analysis of length of circumferential resection margin and distal resection margin. Fixed-effects models were used for 
meta-analysis of circumferential resection margin and distal resection margin involvement. Mean differences and risk ratios are 
shown with 95% confidence intervals (CIs). TaTME, transanal total mesorectal excision; LaTME, laparoscopic total mesorectal 
excision; SD, standard deviation; IV, inverse variance; df, degree of freedom.
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studies (I2 = 0%; P = 0.550).
Publication bias
Symmetrical funnel plots of the conversion rate, major 
complication (Clavien-Dindo classification III−V), CRM 
involvement, and incompleteness of mesorectum suggested no 
publication bias exists in the meta-analysis (Supplementary Fig. 












Heterogeneity: Tau = 46.42; Chi = 62.50, df = 8 (P < 0.001); I = 87%
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Heterogeneity: Chi = 7.81, df = 7 (P = 0.35); I = 10%
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Heterogeneity: Chi = 6.88, df = 8 (P = 0.55); I = 0%
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DISCUSSION
In the present systematic review and meta-analysis, we 
evaluated the bottom-up approach of TaTME compared 
to conventional LaTME with respect to perioperative and 
pathological outcomes. Our meta-analysis shows that TaTME 
has a significantly lower conversion rate compared to LaTME. 
Open surgical conversion is one of the major problems in 
laparoscopic surgery for rectal cancer. Conversion rates in 
laparoscopic surgery depend on several factors such as patient-
related factors, surgeon-related factors, and procedural factors. 
Unlike other factors, patient-related factors are beyond the 
control of the surgeon. Therefore, to determine the success of 
the laparoscopic approach, it is important to consider patient-
related factors such as sex, obesity, tumor stage, and previous 
abdominal operation [40-42]. Furthermore, patient selection 
based on accurate tumor characteristics can reduce conversion 
rates [43]. TaTME has emerged as a feasible alternative surgical 
option for conventional laparoscopic surgery, particularly in 
patients with obesity, narrow pelvis, or deep anterior rectal 
tumors [44]. Notably, our pooled analysis showed significantly 
lower conversion rates in patients undergoing TaTME (Fig. 
2C), suggesting that the transanal approach can overcome 
limitations on patient-related factors. 
While several studies have reported that the 2-team approach 
of the TaTME procedure has shorter operation times, but 
this issue is one of the major controversies currently being 
raised. In the studies included in our meta-analysis, a 2-team 
approach [24,35], a 1-team approach [28,30,32,34,36,38], and 
both approaches [25,27,31] were performed. The 2-team 
approach tended to have shorter operation times compared 
to the 1-team approach, but there were not enough literatures 
available for subgroup analysis. TaTME’s approach may be 
carried out differently depending on the circumstances, such 
as the national healthcare system and health insurance policies 
or the status of medical personnel in hospitals. In this regard, a 
recent study reported cost analysis, including surgical supplies 
along with surgical outcomes [45]. When discussing TaTME’s 
approach in the future, surgical outcomes such as operation 
time and cost analysis also need to be considered.
Anastomotic leakage is a major complication of colorectal 
surgery causing increased mortality, the incidence of which has 
persisted over the last years [46,47]. Recently, an international 
multicenter cohort study reported that TaTME had a higher 
risk of anastomotic leakage than LaTME [13]. On the other 
hand, a recent cohort study of the incidence of anastomosis and 
learning curves after TaTME reported that surgeon proficiency 
can have a positive effect on the occurrence of anastomotic 
leakage. Our findings on the perioperative outcomes showed 
that LaTME tended to have a higher rate of anastomotic leakage 
than TaTME, but there was no statistically significant difference 
(Fig. 4B). Since a wide range of anastomotic leak rates depends 
on the definition, clinical setting, and follow-up period [29], 
subgroup analysis of the related factors needs to be conducted 
through large-scale study to draw clear conclusions.
A Norwegian research group noted that TaTME could increase 
the risk of local recurrence [48]. The results showed local 
recurrence of a new pattern characterized by rapid, multifocal 
growth in the pelvic cavity and sidewalls early after TaTME, 
which led to a nationwide discontinuance of TaTME [48,49]. 
It should be noted that although there are concerns about the 
risk of local recurrence, conclusions cannot be drawn due to 
insufficient numbers and lack of long-term oncological follow-
up from the national multicenter study. These results further 
suggest that structured training with proctorship experienced 
proponents is essential.
One of the potential benefits of TaTME is improved 
specimen quality, defined as CRM involvement, DRM distance, 
and mesorectal completeness. These pathological outcomes 
are the most potent prognostic factors predicting local 
recurrence [50,51]. Fifteen studies involving 1,863 patients 
showed a tendency to a reduced CRM positive status of TaTME 
in comparison with LaTME (Fig. 5A). Regarding the DRM 
distance, 4 of 9 studies reported that TaTME showed a longer 
DRM compared to LaTME [24,25,31,35] (Fig. 5D). Furthermore, 
incompleteness of mesorectum in TaTME was similar to the 
results from LaTME (Fig. 5E). However, contrary to the results 
reported in the individual studies, meta-analysis showed 
TaTME did not lead to significant improvement in pathological 
outcomes when compared to LaTME.
Among the surgical outcomes of TaTME and LaTME, studies 
evaluating the length of CRM and DRM showed considerable 
heterogeneity, and there is one possible explanation for the 
significant heterogeneity. We used the method of estimating 
the median value as the mean value for meta-analysis, and 
it seems that heterogeneity occurred in this process. In the 
study of Alamili et al. [32], the median was similar between 
the 2 groups, but the difference in sample size resulted in a 
large difference in the estimate of the mean value. The main 
limitation of this method is that the outcome distribution is 
assumed to be normal, and new methods have been developed 
to overcome this limitation [52]. However, since any method 
may make an unsuitable assumption, results should be 
interpreted with additional explanations.
In conclusion, this updated systematic review and meta-
analysis showed that TaTME has potential advantages in 
surgical outcomes, suggesting that TaTME can be performed 
as a New Health Technology for rectal cancer patients in South 
Korea. However, since this study was conducted based on 
limited evidence, the results of a well-designed multicenter 
RCTs need to be further evaluated to apply our conclusions 
extensively; and expertise and training to safely perform 
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TaTME should also be considered.
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